How Long Does Your Arm Hurt After a Tdap Shot?

For most people, arm soreness after a Tdap shot lasts one to three days. In a study of pregnant women receiving the vaccine, about 79% reported mild or moderate pain, with the vast majority noticing it within the first 24 hours. Only a small fraction experienced severe soreness, and the discomfort is almost always self-limiting. That said, the range of “normal” is wider than many people expect, and certain factors can push the pain timeline well beyond a few days.

What the Pain Feels Like and When It Starts

The most common complaint after a Tdap shot is localized tenderness right at the injection site, usually in the upper arm’s deltoid muscle. You might also notice some redness, mild swelling, or warmth around the spot. In the observational study of pregnant women, pain onset occurred within 24 hours for roughly 84% of participants, and roughly 2.6% described the pain as severe.¹ Most people feel the worst of it in the first 24 to 48 hours, with steady improvement after that. By day three or four, the majority of recipients have either forgotten about it or are dealing with only a trace of tenderness when they press the spot.

That same study found an interesting geographic difference: participants in the study’s northern sites reported more intense pain, later onset, and a longer time until it fully resolved compared to those in southern sites. The researchers didn’t pin down a definitive cause, but factors like ambient temperature, differences in injection technique across clinics, and individual variation all likely played a role. The takeaway is that “normal” arm soreness after Tdap is a bit of a moving target. If yours lingers into day four or five but is gradually fading, that’s still within the expected range.

Why Your Arm Hurts in the First Place

The soreness isn’t a sign that something went wrong. It’s your immune system responding to the vaccine’s antigens. Tdap contains inactivated components of three bacteria (tetanus, diphtheria, and pertussis), and when those components are deposited into the deltoid muscle, your body sends immune cells rushing to the area. That inflammatory response is how you build protective antibodies, but it also causes the swelling, warmth, and tenderness that make the arm sore. The pain is essentially collateral damage from a process that is working exactly as intended.

A helpful comparison: modern Tdap uses acellular pertussis components, meaning only selected pieces of the pertussis bacterium rather than the whole killed cell. This is a deliberate design choice. Acellular pertussis vaccines were adopted in most high-income countries primarily because they cause fewer and milder side effects than the older whole-cell versions.² A clinical trial comparing the two formulations found that severe pain at the injection site occurred in about 8% of infants after a whole-cell pertussis dose but in none of the infants who received the acellular version.³ So while Tdap still causes arm pain for most recipients, the soreness is considerably milder than it would have been a generation ago with the whole-cell vaccine.

Who Tends to Get More Soreness

Individual variation matters a lot. Some people barely notice the injection, while others have a throbbing arm for the better part of a week. A few patterns emerge from the research, though none are absolute rules.

People who have received multiple tetanus-containing vaccine doses in a relatively short period sometimes have more pronounced local reactions. This is because their immune systems are already primed and can mount a faster, more aggressive inflammatory response at the injection site. Large injection site reactions involving most of the upper arm can occur within hours of booster doses of Tdap, particularly in people with higher pre-existing antibody levels.⁴ These reactions, sometimes called Arthus-type hypersensitivity reactions, look alarming because the swelling can extend well beyond the injection site, but they are self-limiting and resolve without lasting effects over several days.

Body size and composition play a role too, though not in the direction you might expect. A smaller person with less tissue overlying the deltoid muscle may be more vulnerable to a deeper-than-intended injection, which can contribute to more significant pain. Injection technique and needle length are the mediating factors here, and they’re covered in more detail below.

Managing the Soreness

The standard advice for post-vaccination arm pain is straightforward: move the arm, apply a cool compress, and take an over-the-counter pain reliever like ibuprofen or acetaminophen if you need it. Gentle movement helps because it promotes blood flow to the area and prevents the muscle from stiffening up. Sitting still with your arm clamped to your side often makes the next-day soreness worse, not better.

Ice is a popular home remedy, and there’s some research on whether it actually helps. A randomized controlled trial tested ice application immediately after immunization and found that the median pain scores at the time of injection were similar between the ice group and the control group. However, at 24 hours after the shot, about 42% of the ice group reported localized pain compared to roughly 69% of the control group.⁵ The difference didn’t reach statistical significance in that small trial, but the trend was in the direction of ice helping with next-day soreness. It’s unlikely to hurt, and many people find it soothing regardless of what the numbers say.

One thing to avoid: pre-medicating with pain relievers before the shot. Some earlier concerns suggested that taking ibuprofen or acetaminophen before vaccination might blunt the immune response. The evidence on this is mixed and mostly studied in children, but the general recommendation is to wait until after the injection and take pain medication only if you actually need it.

When Swelling Covers Most of Your Arm

Occasionally, the reaction after a Tdap booster is dramatic enough that the redness and swelling extend across most of the upper arm, or even past the elbow. These large injection site reactions can look a lot like a skin infection, which leads to a common and costly mistake: unnecessary antibiotic prescriptions. Clinicians sometimes misdiagnose these reactions as bacterial cellulitis, especially when the redness spreads rapidly and the skin feels hot.⁴

The key difference is timing. A large vaccine-site reaction typically shows up within hours of the shot and begins improving within a couple of days. Bacterial cellulitis from a contaminated injection site would worsen progressively, often with fever, spreading red streaks, and increasing pain rather than improving pain. If you develop extensive redness and swelling but you feel generally fine and the worst of it came on quickly after the shot, you’re most likely looking at an exaggerated immune response rather than an infection. Still, if the swelling keeps expanding after 48 hours or you develop a fever, it’s worth a call to your doctor to rule out something else.

The true Arthus reaction, a specific type of immune-mediated local reaction involving immune complex deposition, is extremely rare after Tdap. An analysis of the U.S. Vaccine Adverse Event Reporting System estimated the reporting rate at roughly 0.1 per million doses distributed, and increasing frequency of repeat Tdap dosing in adults has not led to a detectable rise in these reports.⁶

Shoulder Injury Related to Vaccine Administration

If your arm pain after a Tdap shot is severe from the start, doesn’t improve over the first week, and is accompanied by difficulty lifting or rotating your arm, the problem may not be the vaccine itself but where the needle went. Shoulder Injury Related to Vaccine Administration, or SIRVA, is a recognized condition caused by an injection that lands too high on the arm or too deep into the shoulder structures rather than squarely in the deltoid muscle. One case report describes a healthy adult woman who developed acute shoulder pain and fatigue within hours of a tetanus-containing vaccine, consistent with SIRVA.⁷

SIRVA can involve inflammation of the bursa (the fluid-filled sac that cushions the shoulder joint), damage to rotator cuff tissue, or irritation of the bone itself. The pain pattern is distinct from typical post-vaccination soreness: instead of a dull ache in the meaty part of the deltoid that fades over a few days, SIRVA produces sharper shoulder-joint pain that worsens with overhead movements and persists for weeks or months. Risk factors include a longer needle combined with a smaller body frame and an injection placed too far toward the top of the shoulder.⁸

SIRVA is uncommon, and most cases respond to physical therapy, anti-inflammatory medication, or corticosteroid injections into the shoulder. But it’s worth knowing about because the treatment path is entirely different from the “wait it out” approach that works for ordinary vaccine soreness. If you’re still having significant shoulder pain two weeks after your Tdap shot and it’s limiting your range of motion, bring it up with your provider rather than assuming it’s a slow-healing normal reaction.

How Needle Length and Injection Technique Affect Pain

The goal of a Tdap injection is to deposit the vaccine into the deltoid muscle, not the fat layer above it and not the deeper structures below it. This sounds simple, but it’s surprisingly easy to get wrong, and the consequences show up as more pain. A study using MRI to simulate vaccine injections with different needle lengths found that a standard 1-inch needle penetrated beyond the deltoid muscle and past the subdeltoid fascia in the vast majority of participants: 216 out of 222 men and 270 out of 287 women.⁹ A shorter half-inch needle stayed within the deltoid muscle in 100% of cases.

This matters because injecting too deep can deposit the vaccine near or into the bursa, tendons, or bone, which is how SIRVA happens. On the other hand, going too shallow (into the subcutaneous fat layer rather than the muscle) also has downsides for pain. A study comparing subcutaneous and intramuscular Tdap injections in healthcare workers found that the intramuscular group reported significantly lower pain scores than the subcutaneous group, with a median pain rating of 1 out of 10 versus 3 out of 10.¹⁰ Redness and hardening at the injection site were also more common after subcutaneous injection.

You don’t have much control over needle selection or technique as the person receiving the shot, but you can do a couple of things. Wearing a shirt that allows easy access to the full deltoid (not just the very top of the shoulder) helps the vaccinator pick the right spot. Letting your arm hang relaxed at your side keeps the muscle from tensing up, which can make the injection feel sharper and potentially push the needle off course. And if you have a notably small frame, it’s perfectly reasonable to mention that to the person giving the injection, since they may opt for a shorter needle.

Tdap During Pregnancy

Pregnant women are routinely recommended to get a Tdap booster during each pregnancy, typically between weeks 27 and 36, to pass protective antibodies against pertussis to the baby before birth. This means many people encounter Tdap side effects during a time when they’re already dealing with body aches, fatigue, and general physical discomfort, which can make the arm pain feel more burdensome than it otherwise would.

The safety data on Tdap in pregnancy is reassuring. In the observational study mentioned earlier, pain was the most commonly reported reaction, with about 79% of pregnant participants reporting mild or moderate soreness and only about 2.6% describing it as severe.¹ The pain profile was broadly similar to what non-pregnant adults experience. There’s no evidence that pregnancy amplifies the local reaction, though the general fatigue of the third trimester can make even mild arm soreness feel more annoying than it would at other times.

One practical tip for pregnant women: get the shot in whichever arm you sleep on less. Third-trimester sleep is already hard enough without rolling onto a sore injection site at 3 a.m.

A Rough Timeline to Expect

Pulling the evidence together, here’s what a typical course of post-Tdap arm pain looks like, though individual experiences vary:

First few hours: Mild tenderness develops at the injection site. You might not notice it unless you press on the spot or lift something heavy.
12 to 24 hours: Pain usually peaks. The deltoid feels sore to the touch, and raising the arm overhead may be uncomfortable. Some redness or mild swelling may appear.
Days 2 to 3: Gradual improvement. The soreness shifts from a constant ache to something you notice only when using the arm in certain ways.
Days 4 to 5: Most people are back to normal or very close to it. A faint tenderness when pressing the injection spot may linger.
Beyond one week: If significant pain persists at this point, especially with limited range of motion in the shoulder, it’s time to check in with a healthcare provider to rule out SIRVA or another complication.

This timeline applies to the typical mild-to-moderate reaction. The large injection site reactions described earlier, where swelling extends across most of the upper arm, can take a full week to fully resolve even though they’re still considered benign. And the rare cases of SIRVA can produce shoulder symptoms lasting weeks to months, which is why the distinction between deltoid-muscle soreness and shoulder-joint pain matters so much.

Which Arm to Choose

A question that comes up surprisingly often is whether to get the shot in your dominant or non-dominant arm. The conventional wisdom is to choose the non-dominant arm so the soreness doesn’t interfere with writing, eating, or working. But there’s a competing argument: choosing your dominant arm means you’ll naturally move it more throughout the day, which can help disperse the vaccine and reduce stiffness. Neither approach has strong clinical evidence behind it, so it comes down to your daily life. If you have a desk job and won’t be lifting anything heavy, your dominant arm is fine. If you’re a carpenter or you play recreational sports, go with the non-dominant side. If you’re getting multiple injections at the same visit, splitting them between arms can also help so neither side takes the full brunt.

The one scenario where arm choice truly matters is if you have a pre-existing shoulder condition on one side, like a rotator cuff injury or bursitis. Getting a vaccine in an already-inflamed shoulder raises the risk that any injection-site inflammation will compound the existing problem, and it also makes it harder to distinguish between vaccine soreness and a flare of the underlying condition. In that case, always choose the healthier shoulder.